BG106959A - Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate - Google Patents

Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate

Info

Publication number
BG106959A
BG106959A BG106959A BG10695902A BG106959A BG 106959 A BG106959 A BG 106959A BG 106959 A BG106959 A BG 106959A BG 10695902 A BG10695902 A BG 10695902A BG 106959 A BG106959 A BG 106959A
Authority
BG
Bulgaria
Prior art keywords
cyclopentyloxy
monohydrate
methoxyphenyl
cis
cyano
Prior art date
Application number
BG106959A
Other languages
Bulgarian (bg)
English (en)
Inventor
Kevin Webb
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG106959A publication Critical patent/BG106959A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG106959A 2000-01-26 2002-07-26 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate BG106959A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17812900P 2000-01-26 2000-01-26
PCT/US2001/001487 WO2001055094A1 (en) 2000-01-26 2001-01-18 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate

Publications (1)

Publication Number Publication Date
BG106959A true BG106959A (en) 2003-05-30

Family

ID=22651319

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106959A BG106959A (en) 2000-01-26 2002-07-26 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate

Country Status (36)

Country Link
US (1) US6699903B2 (es)
EP (1) EP1250313B1 (es)
JP (1) JP2003520842A (es)
KR (1) KR20020073183A (es)
CN (1) CN1157371C (es)
AP (1) AP1432A (es)
AR (1) AR027273A1 (es)
AT (1) ATE344235T1 (es)
AU (1) AU3282201A (es)
BG (1) BG106959A (es)
BR (1) BR0107709A (es)
CA (1) CA2397758A1 (es)
CO (1) CO5300517A1 (es)
CY (1) CY1108515T1 (es)
CZ (1) CZ20022590A3 (es)
DE (1) DE60124221T2 (es)
DK (1) DK1250313T3 (es)
DZ (1) DZ3285A1 (es)
EA (1) EA200200791A1 (es)
EG (1) EG24065A (es)
ES (1) ES2273804T3 (es)
HK (1) HK1051030A1 (es)
HU (1) HUP0204150A3 (es)
IL (1) IL150400A0 (es)
MA (1) MA25652A1 (es)
MX (1) MXPA02007300A (es)
MY (1) MY122802A (es)
NO (1) NO20023378D0 (es)
NZ (1) NZ519799A (es)
OA (1) OA12159A (es)
PE (1) PE20011040A1 (es)
PL (1) PL356832A1 (es)
PT (1) PT1250313E (es)
SK (1) SK10942002A3 (es)
WO (1) WO2001055094A1 (es)
ZA (1) ZA200205925B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011802D0 (en) * 2000-05-16 2000-07-05 Smithkline Beecham Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279958B6 (sk) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Zlúčeniny s protialergickým a protizápalovým účink
UA67753C2 (uk) * 1997-10-10 2004-07-15 Смітклайн Бічам Корпорейшн Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

Also Published As

Publication number Publication date
HUP0204150A2 (hu) 2003-04-28
ZA200205925B (en) 2003-11-21
NO20023378L (no) 2002-07-12
ES2273804T3 (es) 2007-05-16
MY122802A (en) 2006-05-31
CZ20022590A3 (cs) 2003-01-15
PE20011040A1 (es) 2001-10-31
AP1432A (en) 2005-06-20
EG24065A (en) 2008-05-08
DK1250313T3 (da) 2007-02-12
MA25652A1 (fr) 2002-12-31
PT1250313E (pt) 2007-01-31
SK10942002A3 (sk) 2002-11-06
HUP0204150A3 (en) 2003-05-28
AR027273A1 (es) 2003-03-19
BR0107709A (pt) 2002-11-19
DZ3285A1 (fr) 2001-08-02
CY1108515T1 (el) 2014-04-09
CN1395556A (zh) 2003-02-05
AP2002002566A0 (en) 2002-06-30
ATE344235T1 (de) 2006-11-15
CN1157371C (zh) 2004-07-14
EP1250313A4 (en) 2005-09-21
US20030032670A1 (en) 2003-02-13
EP1250313A1 (en) 2002-10-23
IL150400A0 (en) 2002-12-01
EA200200791A1 (ru) 2002-12-26
JP2003520842A (ja) 2003-07-08
DE60124221D1 (de) 2006-12-14
EP1250313B1 (en) 2006-11-02
PL356832A1 (en) 2004-07-12
CA2397758A1 (en) 2001-08-02
WO2001055094A1 (en) 2001-08-02
NO20023378D0 (no) 2002-07-12
HK1051030A1 (zh) 2003-07-18
KR20020073183A (ko) 2002-09-19
NZ519799A (en) 2004-04-30
AU3282201A (en) 2001-08-07
OA12159A (en) 2006-05-08
US6699903B2 (en) 2004-03-02
CO5300517A1 (es) 2003-07-31
DE60124221T2 (de) 2007-09-13
MXPA02007300A (es) 2002-11-29

Similar Documents

Publication Publication Date Title
IL160545A0 (en) (-)-1-(3,4-dichlorophenyl) -3- azabicyclo [3.1.0] hexane, compositions thereof and uses as a dopamine-reuptake inhibitor
DE60112974D1 (en) Carbolinderivate
CA2260337A1 (en) Therapeutic agents
IL166510A0 (en) 1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5
HK1062885A1 (en) Spiropyrazole compounds
HK1067129A1 (en) A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds
CA2379614A1 (en) Fragrance emitting device
PT1334720E (pt) Preparações que contêm nateglinida
ZA200205193B (en) Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl.
IL190905A0 (en) 4-alkoxy cyclohexane-1-amino carboxylic acids and processes for their prepatation
DE60216233D1 (en) Carbolinderivate
HK1068877A1 (en) Process for the production of beraprost and its salts
EP2039693A3 (en) Novel synthesis of irbesartan
CA2360024A1 (en) Process for the preparation of non-steroidal glucocorticoid receptor modulators
AP2001002220A0 (en) Calcilytic compounds.
EP1026162A4 (en) ANTI-RHUMATISMAL AGENT
BG106959A (en) Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate
AU2003240634A1 (en) Method for producing bicalutamide
BG103320A (en) Method for the alkylating hindered sulphonamides
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
WO2002053537A8 (en) Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
WO2003106415A3 (en) PROCESSES FOR THE PRODUCTION OF (R) -ETHYL 4-CYANO-3-HYDROXYBUTYRIC ACID
YU62800A (sh) Postupak za proizvodnju r-(+)-6- karboksamido-3n-metilamino- 1,2,3,4-tetrahidrokarbazola
MY117689A (en) A new process for the preparation of 3-n, n-dicycobutylamino-8-fluoro-3, 4-dihydro-2h-1-benzopyran-5-carboxamide